141 related articles for article (PubMed ID: 6167886)
21. Preliminary results for treatments in subacute sclerosing panencephalitis have problems?
Anlar B
J Child Neurol; 2004 Jun; 19(6):463; author reply 463-4. PubMed ID: 15446398
[No Abstract] [Full Text] [Related]
22. Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man.
Gagnon A; Bouchard RW
Arch Neurol; 2003 Aug; 60(8):1160-1. PubMed ID: 12925376
[TBL] [Abstract][Full Text] [Related]
23. Use of isoprinosine in subacute sclerosing panencephalitis.
McGrath E; Rosenbloom L
Arch Dis Child; 1980 Oct; 55(10):829-30. PubMed ID: 6159826
[No Abstract] [Full Text] [Related]
24. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
DuRant RH; Dyken PR; Swift AV
J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
[TBL] [Abstract][Full Text] [Related]
25. [Changes of cognitive and emotional processes during immunostimulatory treatment in subacute sclerosing panencephalitis].
Jakubowska T; Luczywek E; Sobczyk W; Piłkowska E
Neurol Neurochir Pol; 1993; 27(1):45-53. PubMed ID: 7684827
[TBL] [Abstract][Full Text] [Related]
26. Subacute sclerosing panencephalitis. Current status.
Dyken PR
Neurol Clin; 1985 Feb; 3(1):179-96. PubMed ID: 2581121
[TBL] [Abstract][Full Text] [Related]
27. Long-term study of isoprinosine in a case of subacute sclerosing panencephalitis.
De Reuck JL; Boon PA; Krahel NL
Eur Neurol; 1985; 24(5):294-7. PubMed ID: 2414109
[TBL] [Abstract][Full Text] [Related]
28. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
Gupta E; Dar L; Singh S; Behari M; Broor S
Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
[TBL] [Abstract][Full Text] [Related]
29. [Isoprinosine therapy of subacute sclerosing panencephalitis].
Goetz O
Monatsschr Kinderheilkd; 1981 Nov; 129(11):655-7. PubMed ID: 6172706
[No Abstract] [Full Text] [Related]
30. Isoprinosine in SSPE.
Addy DP
Neurology; 1980 Nov; 30(11):1255-6. PubMed ID: 6158715
[No Abstract] [Full Text] [Related]
31. Neuro-ophthalmology of subacute sclerosing panencephalitis: two cases and a review of the literature.
Colpak AI; Erdener SE; Ozgen B; Anlar B; Kansu T
Curr Opin Ophthalmol; 2012 Nov; 23(6):466-71. PubMed ID: 23047165
[TBL] [Abstract][Full Text] [Related]
32. Inosiplex in the treatment of subacute sclerosing panencephalitis.
Silverberg R; Brenner T; Abramsky O
Arch Neurol; 1979 Jun; 36(6):374-5. PubMed ID: 88215
[TBL] [Abstract][Full Text] [Related]
33. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
[TBL] [Abstract][Full Text] [Related]
34. Current developments in the management of subacute sclerosing panencephalitis.
Panagariya A; Sureka RK; Aurora A
J Assoc Physicians India; 1998 Feb; 46(2):218-20. PubMed ID: 11273118
[No Abstract] [Full Text] [Related]
35. A Multinational Survey on Actual Diagnostics and Treatment of Subacute Sclerosing Panencephalitis.
Häusler M; Aksoy A; Alber M; Altunbasak S; Angay A; Arsene OT; Craiu D; Hartmann H; Hiz-Kurul S; Ichiyama T; Iliescu C; Jocic-Jakubi B; Korinthenberg R; Köse G; Lukban MB; Ozkan M; Patcheva I; Teichler J; Vintan M; Yaramis A; Yarar C; Yis U; Yuksel D; Anlar B
Neuropediatrics; 2015 Dec; 46(6):377-84. PubMed ID: 26479761
[TBL] [Abstract][Full Text] [Related]
36. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
Jones CE; Dyken PR; Huttenlocher PR; Jabbour JT; Maxwell KW
Lancet; 1982 May; 1(8280):1034-7. PubMed ID: 6176821
[TBL] [Abstract][Full Text] [Related]
37. SSPE incidence, therapy receive renewed attention.
Gunby P
JAMA; 1981 Aug; 246(9):927, 931-2. PubMed ID: 6166765
[No Abstract] [Full Text] [Related]
38. The interferon system in subacute sclerosing panencephalitis and its response to isoprinosine.
Gadoth N; Kott E; Levin S; Hahn T
Brain Dev; 1989; 11(5):308-12. PubMed ID: 2479277
[TBL] [Abstract][Full Text] [Related]
39. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.
Anlar B; Guven A; Köse G; Okur H; Kose O; Aydin OF; Kabakus N; Altunbasak S; Herguner O; Sonmez M; Serdaroglu A
J Neuroimmunol; 2005 Jun; 163(1-2):195-8. PubMed ID: 15885323
[TBL] [Abstract][Full Text] [Related]
40. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.
Gascon GG;
J Child Neurol; 2003 Dec; 18(12):819-27. PubMed ID: 14736075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
